Prognostic microRNA expression signature from examination of colorectal primary and metastatic tumors

Anticancer Research

Volumn 34, Issue 8, 2014, Pages 3957-3968

  Ellermeier, Chad ^a   Vang, Souriya ^a   Cleveland, Kelly ^a   Durand, Wesley ^a   Resnick, Murray B ^a   Brodsky, Alexander S ^a,b  

^a BROWN UNIVERSITY   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

Colorectal cancer; Metastasis; MicroRNAs

Indexed keywords

MICRORNA; MICRORNA 100; MICRORNA 10B; MICRORNA 122; MICRORNA 133B; MICRORNA 138; MICRORNA 142 5P; MICRORNA 196B; MICRORNA 210; MICRORNA 218; MICRORNA 223; MICRORNA 424; MICRORNA 483 5P; MICRORNA 523; MICRORNA 548A 3P; MICRORNA 618; MICRORNA 708; MICRORNA 885 5P; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER PROGNOSIS; CANCER SURVIVAL; CLINICAL ARTICLE; COLORECTAL LIVER METASTASIS; CONTROLLED STUDY; ELECTRONIC MEDICAL RECORD; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; LASER CAPTURE MICRODISSECTION; MALE; METASTATIC COLORECTAL CANCER; OVERALL SURVIVAL; POLYMERASE CHAIN REACTION; PRIMARY TUMOR; RETROSPECTIVE STUDY; COLORECTAL CANCER; COLORECTAL TUMOR; GENE EXPRESSION REGULATION; GENETICS; LIVER TUMOR; METASTASIS; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; VERY ELDERLY;

COLORECTAL CANCER; METASTASIS; MICRORNAS;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS;

EID: 84908689776     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. World Cancer Research Fund International. Available from: http://www.wcrf.org/cancer-statistics/ [last accessed March 3, 2014].
2. Van den Eynden GG, Majeed AW, Illemann M, Vermeulen PB, Bird NC, Høyer-Hansen G, Eefsen RL, Reynolds AR and Brodt P: The multifaceted role of the microenvironment in liver metastasis: biology and clinical implications. Cancer Res 73: 2031-2043, 2013.
3. Vermaat JS, Nijman IJ, Koudijs MJ, Gerritse FL, Scherer SJ, Mokry M, Roessingh WM, Lansu N, de Bruijn E, van Hillegersberg R, van Diest PJ, Cuppen E and Voest EE: Primary colorectal cancers and their subsequent hepatic metastases are genetically different: implications for selection of patients for targeted treatment. Clin Cancer Res 18: 688-699, 2012.
4. Vang S, Wu H-T, Fischer A, Miller DH, MacLaughlan S, Douglass E, Steinhoff M, Collins C, Smith PJS, Brard L and Brodsky AS: Identification of ovarian cancer metastatic miRNAs. PLoS ONE 8: e58226, 2013.
5. Iorio MV and Croce CM: MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol Med 4: 143-159, 2012.
6. Akc¸akaya P, Ekelund S, Kolosenko I, Caramuta S, Ozata DM, Xie H, Lindforss U, Olivecrona H and Lui W-O: miR-185 and miR-133b deregulation is associated with overall survival and metastasis in colorectal cancer. Int J Oncol 39: 311-318, 2011.
7. Pizzini S, Bisognin A, Mandruzzato S, Biasiolo M, Facciolli A, Perilli L, Rossi E, Esposito G, Rugge M, Pilati P, Mocellin S, Nitti D, Bortoluzzi S and Zanovello P: Impact of microRNAs on regulatory networks and pathways in human colorectal carcinogenesis and development of metastasis. BMC Genomics 14: 589, 2013.
8. Ramaswamy S, Ross KN, Lander ES and Golub TR: A molecular signature of metastasis in primary solid tumors. Nat Genet 33: 49-54, 2003.
9. Storey JD and Tibshirani R: Statistical significance for genomewide studies. Proc Natl Acad Sci USA 100: 9440-9445, 2003.
10. Chang J, Nicolas E, Marks D, Sander C, Lerro A, Buendia MA, Xu C, Mason WS, Moloshok T, Bort R, Zaret KS and Taylor JM: miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1. RNA Biol 1: 106-113, 2004.
11. Gui J, Tian Y, Wen X, Zhang W, Zhang P, Gao J, Run W, Tian L, Jia X and Gao Y: Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies. Clin Sci 120: 183-193, 2011.
12. Kang J, D'Andrea AD and Kozono D: A DNA repair pathway-focused score for prediction of outcomes in ovarian cancer treated with platinum-based chemotherapy. J Natl Cancer Inst 104: 670-681, 2012.
13. Brodsky AS, Fischer A, Miller DH, Vang S, MacLaughlan S, Wu H-T, Yu J, Steinhoff M, Collins C, Smith PJS, Raphael BJ and Brard L: Expression profiling of primary and metastatic ovarian tumors reveals differences indicative of aggressive disease. PLoS ONE 9: e94476, 2014.
14. Navon R, Wang H, Steinfeld I, Tsalenko A, Ben-Dor A and Yakhini Z: Novel rank-based statistical methods reveal microRNAs with differential expression in multiple cancer types. PLoS ONE 4: e8003, 2009.
15. Wan Y-W, Mach CM, Allen GI, Anderson ML and Liu Z: On the Reproducibility of TCGA Ovarian Cancer MicroRNA Profiles. PLoS ONE 9: e87782, 2014.
16. Kano M, Seki N, Kikkawa N, Fujimura L, Hoshino I, Akutsu Y, Chiyomaru T, Enokida H, Nakagawa M and Matsubara H: miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma. Int J Cancer 127: 2804-2814, 2010.
17. Zhao H, Li M, Li L, Yang X, Lan G and Zhang Y: MiR-133b is down-regulated in human osteosarcoma and inhibits osteosarcoma cells proliferation, migration and invasion, and promotes apoptosis. PLoS ONE 8: e83571, 2013.
18. Wen D, Li S, Ji F, Cao H, Jiang W, Zhu J and Fang X: miR-133b acts as a tumor suppressor and negatively regulates FGFR1 in gastric cancer. Tumour Biol 34: 793-803, 2013.
19. Chen X-M: MicroRNA signatures in liver diseases. World J Gastroenterol 15: 1665-1672, 2009.
20. Kulshreshtha R, Ferracin M, Wojcik SE, Garzon R, Alder H, Agosto-Perez FJ, Davuluri R, Liu C-G, Croce CM, Negrini M, Calin GA and Ivan M: A microRNA signature of hypoxia. Molecular and cellular biology 27: 1859-1867, 2007.
21. Gee HE, Ivan C, Calin GA and Ivan M: HypoxamiRs and Cancer: From Biology to Targeted Therapy. Antioxid Redox Signal, 2013.
22. Ying Q, Liang L, Guo W, Zha R, Tian Q, Huang S, Yao J, Ding J, Bao M, Ge C, Yao M, Li J and He X: Hypoxia-inducible microRNA-210 augments the metastatic potential of tumor cells by targeting vacuole membrane protein 1 in hepatocellular carcinoma. Hepatology 54: 2064-2075, 2011.
23. Oue N, Anami K, Schetter AJ, Moehler M, Okayama H, Khan MA, Bowman ED, Mueller A, Schad A, Shimomura M, Hinoi T, Aoyagi K, Sasaki H, Okajima M, Ohdan H, Galle PR, Yasui W and Harris CC: High miR-21 expression from FFPE tissues is associated with poor survival and response to adjuvant chemotherapy in colon cancer. Int J Cancer 134: 1926-934, 2014.
24. Almendro V, Kim H, Cheng Y-K, Gonen M, Itzkovitz S, Argani P, van Oudenaarden A, Sukumar S, Michor F and Polyak K: Genetic and phenotypic diversity in breast tumor metastases. Cancer research 74: 1338-1348, 2014.